Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats.
|
Neuropsychopharmacology
|
2002
|
1.45
|
2
|
Delta-opioid agonists: differential efficacy and potency of SNC80, its 3-OH (SNC86) and 3-desoxy (SNC162) derivatives in Sprague-Dawley rats.
|
J Pharmacol Exp Ther
|
2004
|
1.25
|
3
|
Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
|
J Pharmacol Exp Ther
|
2003
|
1.21
|
4
|
Convulsant activity of a non-peptidic delta-opioid receptor agonist is not required for its antidepressant-like effects in Sprague-Dawley rats.
|
Psychopharmacology (Berl)
|
2002
|
1.18
|
5
|
Gonadal hormone modulation of mu, kappa, and delta opioid antinociception in male and female rats.
|
J Pain
|
2005
|
1.10
|
6
|
The selective non-peptidic delta opioid agonist SNC80 does not facilitate intracranial self-stimulation in rats.
|
Eur J Pharmacol
|
2008
|
1.09
|
7
|
The delta-opioid receptor agonist (+)BW373U86 regulates BDNF mRNA expression in rats.
|
Neuropsychopharmacology
|
2004
|
1.05
|
8
|
Interactions between delta and mu opioid agonists in assays of schedule-controlled responding, thermal nociception, drug self-administration, and drug versus food choice in rhesus monkeys: studies with SNC80 [(+)-4-[(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide] and heroin.
|
J Pharmacol Exp Ther
|
2005
|
1.02
|
9
|
A novel and facile preparation of bremazocine enantiomers through optically pure N-norbremazocines.
|
Bioorg Med Chem
|
2004
|
1.00
|
10
|
The convulsive and electroencephalographic changes produced by nonpeptidic delta-opioid agonists in rats: comparison with pentylenetetrazol.
|
J Pharmacol Exp Ther
|
2006
|
0.93
|
11
|
Electroencephalographic and convulsant effects of the delta opioid agonist SNC80 in rhesus monkeys.
|
Pharmacol Biochem Behav
|
2006
|
0.92
|
12
|
Role of delta opioid efficacy as a determinant of mu/delta opioid interactions in rhesus monkeys.
|
Eur J Pharmacol
|
2008
|
0.91
|
13
|
Effects of the δ opioid receptor agonist SNC80 on pain-related depression of intracranial self-stimulation (ICSS) in rats.
|
J Pain
|
2012
|
0.91
|
14
|
Effects of the delta-opioid agonist SNC80 on the abuse liability of methadone in rhesus monkeys: a behavioral economic analysis.
|
Psychopharmacology (Berl)
|
2011
|
0.90
|
15
|
Increased levels of gamma-glutamylamines in Huntington disease CSF.
|
J Neurochem
|
2008
|
0.90
|
16
|
Probes for narcotic receptor mediated phenomena. Part 42: synthesis and in vitro pharmacological characterization of the N-methyl and N-phenethyl analogues of the racemic ortho-c and para-c oxide-bridged phenylmorphans.
|
Bioorg Med Chem
|
2011
|
0.88
|
17
|
Behavioral and neurobiological effects of the enkephalinase inhibitor RB101 relative to its antidepressant effects.
|
Eur J Pharmacol
|
2006
|
0.86
|
18
|
Comparison of peptidic and nonpeptidic delta-opioid agonists on guanosine 5'-O-(3-[35S]thio)triphosphate ([35S]GTPgammaS) binding in brain slices from Sprague-Dawley rats.
|
J Pharmacol Exp Ther
|
2004
|
0.85
|
19
|
The delta-opioid receptor agonist SNC80 [(+)-4-[alpha(R)-alpha-[(2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl]-(3-methoxybenzyl)-N,N-diethylbenzamide] synergistically enhances the locomotor-activating effects of some psychomotor stimulants, but not direct dopamine agonists, in rats.
|
J Pharmacol Exp Ther
|
2007
|
0.85
|
20
|
Effects of the selective delta opioid agonist SNC80 on cocaine- and food-maintained responding in rhesus monkeys.
|
Eur J Pharmacol
|
2006
|
0.84
|
21
|
Inactivation of eukaryotic initiation factor 5A (eIF5A) by specific acetylation of its hypusine residue by spermidine/spermine acetyltransferase 1 (SSAT1).
|
Biochem J
|
2011
|
0.83
|
22
|
Probes for narcotic receptor mediated phenomena. 43. Synthesis of the ortho-a and para-a, and improved synthesis and optical resolution of the ortho-b and para-b oxide-bridged phenylmorphans: compounds with moderate to low opioid-receptor affinity.
|
Bioorg Med Chem
|
2011
|
0.83
|
23
|
Selective enhancement of fentanyl-induced antinociception by the delta agonist SNC162 but not by ketamine in rhesus monkeys: Further evidence supportive of delta agonists as candidate adjuncts to mu opioid analgesics.
|
Pharmacol Biochem Behav
|
2010
|
0.83
|
24
|
Chronic administration of the delta opioid receptor agonist (+)BW373U86 and antidepressants on behavior in the forced swim test and BDNF mRNA expression in rats.
|
Psychopharmacology (Berl)
|
2005
|
0.82
|
25
|
Synthesis and pharmacological evaluation of 3-(3,4-dichlorophenyl)-1-indanamine derivatives as nonselective ligands for biogenic amine transporters.
|
J Med Chem
|
2004
|
0.80
|
26
|
Enantioconvergent synthesis of (-)-(2R,5S)-1-allyl-2,5-dimethylpiperazine, an intermediate to delta-opioid receptor ligands.
|
J Org Chem
|
2003
|
0.77
|
27
|
Interaction between Mu and Delta Opioid Receptor Agonists in an Assay of Capsaicin-Induced Thermal Allodynia in Rhesus Monkeys.
|
Pain Res Treat
|
2012
|
0.77
|